Laurel Crosby

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Laurel Crosby, PhD, is Engineering Research Associate with the Stanford Genome Technology Center.[1]

Notable studies[edit | edit source]

  • 2021, Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole[2] (Full text)
correction

See also[edit | edit source]

References[edit | edit source]

  1. ↑ "Meet Laurel Crosby, PhD, member of the SGTC Team". Open Medicine Foundation. August 8, 2018. Retrieved January 20, 2019.
  2. ↑ Crosby, L. D.; Kalanidhi, S.; Bonilla, A.; Subramanian, A.; Ballon, J.S.; Bonilla, H. (February 3, 2021). "Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole". Journal of Translational Medicine. 19 (1): 50. doi:10.1186/s12967-021-02721-9. ISSN 1479-5876. PMC 7860172. PMID 33536023.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

Retrieved from "https://me-pedia.org/w/index.php?title=Laurel_Crosby&oldid=225929"